Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study.
RMD open（2022）
摘要
Malignancy risk in Korean patients with RA was not increased with JAKi use compared with TNFi use.
更多查看译文
关键词
Epidemiology,Rheumatoid Arthritis,Therapeutics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要